Cognition Therapeutics (CGTX) Interest & Investment Income (2023 - 2026)
Cognition Therapeutics (CGTX) reported Interest & Investment Income of -$5000.0 for Q1 2026, little changed year-over-year from -$5000.0 in Q1 2025, and little changed on a QoQ basis from -$5000.0 in Q4 2025.
Cognition Therapeutics (CGTX) has 4 years of Interest & Investment Income data on file, last reported at -$5000.0 in Q1 2026.
- Quarterly Interest & Investment Income changed 0.0% year-over-year to -$5000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$13000.0 (up 35.0% YoY) and the FY2025 annual result came in at -$13000.0, up 48.0% from the prior year.
- Interest & Investment Income steadied at -$5000.0 in Q1 2026 per CGTX's latest filing, from -$5000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at -$2000.0 in Q3 2023 and bottomed at -$10000.0 in Q1 2024.
- The 4-year median for Interest & Investment Income is -$5000.0 (2024), against an average of -$5454.5.
- The widest annual swing landed in 2024, when Interest & Investment Income slumped 50.0%; it then jumped 57.14% in 2025.
- Tracing CGTX's Interest & Investment Income over 4 years: stood at -$9000.0 in 2023, then surged by 44.44% to -$5000.0 in 2024, then changed by 0.0% to -$5000.0 in 2025, then changed by 0.0% to -$5000.0 in 2026.
- Per Business Quant, the three latest CGTX Interest & Investment Income figures stand at -$5000.0 (Q1 2026), -$5000.0 (Q4 2025), and -$3000.0 (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | 305,000.00 |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Cognition Therapeutics | 648,270.00 | 648,270.00 | - | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,000.00 |
| Dec 31, 2025 | -5,000.00 |
| Jun 30, 2025 | -3,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -5,000.00 |
| Sep 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -7,000.00 |
| Mar 31, 2024 | -10,000.00 |
| Dec 31, 2023 | -9,000.00 |
| Sep 30, 2023 | -2,000.00 |
| Jun 30, 2023 | -6,000.00 |